Car-T For Lymphoma: New Targets, Real World Data & Resistance

CAR-T for lymphoma: new targets, real world data & resistance

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Lekakis on Real-World Data With CAR T-Cell Therapy in Lymphoma

Updates on CAR-T therapies in NHL: real-world data, trials & new indications

VJHemOnc – Video Journal of Hematology & HemOnc

Real world data for CD19 CAR-T in lymphoma patients in England

VJHemOnc – Video Journal of Hematology & HemOnc

Analyzing Real-World Data for CAR T-Cell Therapy in Patients With ALL and DLBCL

Targeted Oncology

Real-World CAR-T Data Update

HealthTree Foundation for Multiple Myeloma

CD19 CAR-T for lymphoma: real-world experience in the UK

VJHemOnc – Video Journal of Hematology & HemOnc

Real-World Data and CAR T Therapy

Real-world efficacy & safety data: CAR-T in DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Real world data: CAR T-cell therapy for hematological cancers

VJHemOnc – Video Journal of Hematology & HemOnc

Copy of Dr. Lekakis on Real-World Data With CAR T-Cell Therapy in Lymphoma

UK real-world CD19 CAR-T data - thoughts from Graham Collins

VJHemOnc – Video Journal of Hematology & HemOnc

Lori Leslie, MD, on real-world evidence regarding CAR-T cell therapy in lymphoma

CAR T Cells in B-Cell Lymphoma: Implications of New Data and New Therapy

Real-world efficacy & safety data: CAR-T in DLBCL

CAR T-cell therapy economics in the real world

VJHemOnc – Video Journal of Hematology & HemOnc

Who Should Receive CAR-T Cell Therapy for Lymphoma?

Real World Data on CAR-T Cell Therapy2021 Jian-Jian Luan Award - Wolfgang Bethge

WebsEdgeMedicine

CAR T-cells in lymphoma: new advances and practical aspects

International Academy for Clinical Hematology IACH

Real-world experiences with toxicity in patients treated with CAR-T cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc